Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Profit After Tax (2023 - 2025)

CG Oncology filings provide 3 years of Profit After Tax readings, the most recent being -$41.3 million for Q4 2025.

  • On a quarterly basis, Profit After Tax fell 29.87% to -$41.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$161.0 million, a 82.85% decrease, with the full-year FY2025 number at -$161.0 million, down 82.87% from a year prior.
  • Profit After Tax hit -$41.3 million in Q4 2025 for CG Oncology, up from -$43.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$8.7 million in Q1 2023 to a low of -$43.8 million in Q3 2025.
  • Median Profit After Tax over the past 3 years was -$19.7 million (2024), compared with a mean of -$24.8 million.
  • The widest YoY moves for Profit After Tax: up 29.87% in 2025, down 119.16% in 2025.
  • CG Oncology's Profit After Tax stood at -$16.6 million in 2023, then crashed by 92.07% to -$31.8 million in 2024, then fell by 29.87% to -$41.3 million in 2025.
  • The last three reported values for Profit After Tax were -$41.3 million (Q4 2025), -$43.8 million (Q3 2025), and -$41.4 million (Q2 2025) per Business Quant data.